Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.41+0.11 (+1.33%)
Close on Nov 17, 2026Market cap $488.95MP/E –Yield –
Capricor Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Capricor Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$104.00M. For fiscal 2025 it was -$69.81M. The highest annual figure on record is $4.92M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$69.81M | – |
| FY2024 | Dec 31, 2024 | -$40.00M | – |
| FY2023 | Dec 31, 2023 | -$25.60M | -620.6% |
| FY2022 | Dec 31, 2022 | $4.92M | – |
| FY2021 | Dec 31, 2021 | -$16.81M | – |
| FY2020 | Dec 31, 2020 | -$10.05M | – |
| FY2019 | Dec 31, 2019 | -$6.82M | – |
| FY2018 | Dec 31, 2018 | -$13.86M | – |
| FY2017 | Dec 31, 2017 | -$14.23M | – |
| FY2016 | Dec 31, 2016 | -$14.45M | – |
| FY2015 | Dec 31, 2015 | -$10.82M | -1228.5% |
| FY2014 | Dec 31, 2014 | $958.56K | – |
| FY2013 | Dec 31, 2013 | -$6.14M | – |
| FY2012 | Dec 31, 2012 | -$2.06M | – |
| FY2011 | Dec 31, 2011 | -$4.65M | – |
| FY2010 | Dec 31, 2010 | -$4.32M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$31.49M | – |
| Q1 FY2026 | Mar 31, 2026 | -$29.25M | – |
| Q4 FY2025 | Dec 31, 2025 | -$23.57M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.69M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.12M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.43M | – |
| Q4 FY2024 | Dec 31, 2024 | -$14.80M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.64M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.29M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.27M | -130.1% |
| Q4 FY2023 | Dec 31, 2023 | -$11.59M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.79M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.42M | – |
| Q1 FY2023 | Mar 31, 2023 | $4.21M | -82.5% |
| Q4 FY2022 | Dec 31, 2022 | -$6.90M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.69M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.54M | – |
| Q1 FY2022 | Mar 31, 2022 | $24.05M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.63M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.34M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.51M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.33M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.84M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.98M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.02M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.22M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.79M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.65M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.78M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.61M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.77M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.98M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.69M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.42M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.67M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.19M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.70M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.68M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.48M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.91M | – |
See a number that looks wrong?